On the recordApril 24, 2018
Expediting reviews under NEPA, as some of my colleagues here would have us do, I believe does not address the underlying problem.
Source
congress.govEditor's note · Context
Barragan argues that faster NEPA reviews without funding won't solve project delays.
Share
More from Nanette Barragán
Mar 28, 2023
I disagree with CMS's coverage decision to tightly restrict coverage for an entire class of FDA-approved Alzheimer's drugs.
Apr 5, 2022
Ukrainians should be allowed to enter the United States and seek humanitarian protection. But so should Haitians and Hondurans and Guatemalans, Africans, and others fleeing violence.
Other voices in this conversation
